About

Nexstone Innovation is a biopharma drug development company established by former partners and senior executives from NeXeption. Members of our team have significant operating experience in small- and large-scale entities, both public and private. We have a successful track record developing small-molecule medicines and large-molecule biologics. Over the past 15 years, we have achieved four FDA-approved products and seven strategic company transactions. Our team is deeply experienced in all aspects of drug development and company operation.